Molecular Response enables pharmaceutical partners to realize efficiencies in drug development through use of clinically proven molecular markers. We provide comprehensive clinical trial support services from trial-site sample collection to full clinical analysis.
We routinely apply available standard of care clinical information with clinically valid, novel and proprietary molecular markers to develop high-value knowledge for existing pharmaceutical development processes and programs; the result reduces risk of development and allows for the most informed decision-making possible.
We use only validated methodologies and proven technology platforms to test precious clinical specimens from patients treated with investigational agents. And to fast—track therapeutic approval, we translate biomarker tests into diagnostic assays regulated as Laboratory Developed tests (LDT) under CLIA guidelines or In Vitro Diagnostics (IVD) through the FDA.